FDA Accepts Alvotech's BLA Supporting Interchangeability For ATV02, A High Concentration, Citrate-Free Biosimilar Candidate For Humira® - Food, Drugs, Healthcare, Life Sciences
Alvotech Holdings S.A. ("Alvotech") announced on February 28th that the U.S. Food and Drug Administration (FDA) has accepted for review the company's Biologics Licensing Application (BLA)...
Source: mondaq.com